# CIML NK Cells With Venetoclax for AML

> clinical trial · VERIFIED · 2026-07-24

Status: RECRUITING · Sponsor: Dana-Farber Cancer Institute · Condition: Acute Myeloid Leukemia

- Company: Dana-Farber Cancer Institute
- Sector: Acute Myeloid Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT06152809

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.